Lana Medical Co., which is set to be listed on Nomu-Parallel Market, posted a net profit of SAR 5.5 million for 2022, a decline of 17% compared to SAR 6.6 million a year earlier.
Item | 2021 | 2022 | Change |
---|---|---|---|
Revenues | 31.97 | 40.80 | 27.6 % |
Gross Income | 16.87 | 18.87 | 11.9 % |
Operating Income | 7.32 | 6.56 | (10.3 %) |
Net Income | 6.59 | 5.49 | (16.7 %) |
Average Shares | 3.00 | 3.00 | - |
EPS (Riyals) | 2.20 | 1.83 | (16.7 %) |
The profit decline was attributed to a fall in operating profit margin from 23% to 16% on higher administrative and marketing expenses. This was in addition to lower other income and higher financing charges.
However, revenues increased by 28% to SAR 40.8 million in 2022, compared to SAR 32 million in 2021. Zakat expenses also declined year-on-year (YoY).
Shareholders' equity, no minority interest, totaled SAR 48.42 million by the end of 2022, compared to SAR 41.57 million a year before.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
H1 2020 | - | - | - | - | - | - |
H2 2020 | - | - | - | - | - | - |
2020 | 21.07 | - | 11.44 | - | 4.61 | - |
H1 2021 | - | - | - | - | - | - |
H2 2021 | - | - | - | - | - | - |
2021 | 31.97 | 51.7 % | 16.87 | 47.5 % | 7.32 | 58.9 % |
H1 2022 | - | - | - | - | - | - |
H2 2022 | - | - | - | - | - | - |
2022 | 40.80 | 27.6 % | 18.87 | 11.9 % | 6.56 | (10.3 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
2020 | 21.07 | - | 11.44 | - | 4.61 | - |
2021 | 31.97 | 51.7 % | 16.87 | 47.5 % | 7.32 | 58.9 % |
2022 | 40.80 | 27.6 % | 18.87 | 11.9 % | 6.56 | (10.3 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
H1 2020 | - | - | - | - | - | - |
H2 2020 | - | - | - | - | - | - |
2020 | 4.19 | - | 2.47 | - | 4.19 | 2.47 |
H1 2021 | - | - | - | - | - | - |
H2 2021 | - | - | - | - | - | - |
2021 | 6.59 | 57.3 % | 2.20 | - | 6.59 | 2.20 |
H1 2022 | - | - | - | - | - | - |
H2 2022 | - | - | - | - | - | - |
2022 | 5.49 | (16.7 %) | 1.83 | - | 5.49 | 1.83 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
2020 | 4.19 | - | 2.47 | - | 4.19 | 2.47 |
2021 | 6.59 | 57.3 % | 2.20 | - | 6.59 | 2.20 |
2022 | 5.49 | (16.7 %) | 1.83 | - | 5.49 | 1.83 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
2020 | 54.27 % | 26.09 % | 19.90 % |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
2021 | 52.76 % | 26.27 % | 20.63 % |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
2022 | 46.25 % | 19.83 % | 13.46 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | 54.27 % | 26.09 % | 19.90 % |
2021 | 52.76 % | 26.27 % | 20.63 % |
2022 | 46.25 % | 19.83 % | 13.46 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
H1 2013 | - | - | - | - |
H2 2013 | - | - | - | - |
H1 2014 | - | - | - | - |
H2 2014 | - | - | - | - |
H1 2015 | - | - | - | - |
H2 2015 | - | - | - | - |
H1 2016 | - | - | - | - |
H2 2016 | - | - | - | - |
H1 2017 | - | - | - | - |
H2 2017 | - | - | - | - |
H1 2018 | - | - | - | - |
H2 2018 | - | - | - | - |
H1 2019 | - | - | - | - |
H2 2019 | - | - | - | - |
H1 2020 | - | - | - | - |
H2 2020 | - | - | - | - |
H1 2021 | - | - | - | - |
H2 2021 | - | - | - | - |
H1 2022 | - | - | - | - |
H2 2022 | - | - | - | - |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2013 | - | - | - | - |
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | - | - | - | - |
2020 | 1.70 | 2.47 | 2.47 | 12.87 |
2021 | 3.00 | 2.20 | 2.20 | 13.86 |
2022 | 3.00 | 1.83 | 1.83 | 15.81 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | - | - | - |
2022 | - | - | - |
2022
2022
Period | Medical waste treatment | Medical supplies | Medical devices |
---|
Period | Medical waste treatment | Medical supplies | Medical devices |
---|---|---|---|
2021 | 15.52 | - | 16.45 |
2022 | 20.11 | 7.35 | 13.34 |
Current | |
Market Cap (M Riyal) | 132.12 |
Enterprise Value (EV) (M) | 118.88 |
Shares Outstanding ((M)) | 3.60 |
Book Value (BV) ( Riyal) | 18.90 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 43.90 |
Price/book | 1.94 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}